ID   KCTD7_HUMAN             Reviewed;         289 AA.
AC   Q96MP8; A4D2M4; Q8IVR0;
DT   03-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   18-JUN-2025, entry version 170.
DE   RecName: Full=BTB/POZ domain-containing protein KCTD7;
GN   Name=KCTD7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z., Lu F., Zeesman S.,
RA   Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F., Belloni E.,
RA   Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A.P., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M., Gripp K.W.,
RA   Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H., Teebi A.,
RA   Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X.,
RA   Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E.,
RA   Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INVOLVEMENT IN EPM3.
RX   PubMed=17455289; DOI=10.1002/ana.21121;
RA   Van Bogaert P., Azizieh R., Desir J., Aeby A., De Meirleir L., Laes J.-F.,
RA   Christiaens F., Abramowicz M.J.;
RT   "Mutation of a potassium channel-related gene in progressive myoclonic
RT   epilepsy.";
RL   Ann. Neurol. 61:579-586(2007).
RN   [6]
RP   SUBCELLULAR LOCATION, INTERACTION WITH CUL3, VARIANT EPM3 CYS-184, AND
RP   CHARACTERIZATION OF VARIANT EPM3 CYS-184.
RX   PubMed=22748208; DOI=10.1016/j.ajhg.2012.05.023;
RA   Staropoli J.F., Karaa A., Lim E.T., Kirby A., Elbalalesy N., Romansky S.G.,
RA   Leydiker K.B., Coppel S.H., Barone R., Xin W., MacDonald M.E.,
RA   Abdenur J.E., Daly M.J., Sims K.B., Cotman S.L.;
RT   "A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis to the
RT   ubiquitin-proteasome system.";
RL   Am. J. Hum. Genet. 91:202-208(2012).
RN   [7]
RP   SUBCELLULAR LOCATION, AND VARIANTS EPM3 TRP-94; MET-108; TYR-115 AND
RP   ILE-273.
RX   PubMed=22693283; DOI=10.1136/jmedgenet-2012-100859;
RA   Kousi M., Anttila V., Schulz A., Calafato S., Jakkula E., Riesch E.,
RA   Myllykangas L., Kalimo H., Topcu M., Gokben S., Alehan F., Lemke J.R.,
RA   Alber M., Palotie A., Kopra O., Lehesjoki A.E.;
RT   "Novel mutations consolidate KCTD7 as a progressive myoclonus epilepsy
RT   gene.";
RL   J. Med. Genet. 49:391-399(2012).
RN   [8]
RP   INVOLVEMENT IN OPSOCLONUS-MYOCLONUS ATAXIA-LIKE SYNDROME, AND VARIANT
RP   TRP-84.
RX   PubMed=22638565; DOI=10.1007/s00415-012-6545-z;
RA   Blumkin L., Kivity S., Lev D., Cohen S., Shomrat R., Lerman-Sagie T.,
RA   Leshinsky-Silver E.;
RT   "A compound heterozygous missense mutation and a large deletion in the
RT   KCTD7 gene presenting as an opsoclonus-myoclonus ataxia-like syndrome.";
RL   J. Neurol. 259:2590-2598(2012).
RN   [9]
RP   VARIANT EPM3 TRP-94.
RX   PubMed=22606975; DOI=10.1111/j.1469-1809.2012.00710.x;
RA   Krabichler B., Rostasy K., Baumann M., Karall D., Scholl-Burgi S.,
RA   Schwarzer C., Gautsch K., Spreiz A., Kotzot D., Zschocke J., Fauth C.,
RA   Haberlandt E.;
RT   "Novel mutation in potassium channel related gene KCTD7 and progressive
RT   myoclonic epilepsy.";
RL   Ann. Hum. Genet. 76:326-331(2012).
RN   [10]
RP   VARIANT EPM3 MET-108.
RX   PubMed=22612257; DOI=10.1111/j.1528-1167.2012.03516.x;
RA   Lemke J.R., Riesch E., Scheurenbrand T., Schubach M., Wilhelm C.,
RA   Steiner I., Hansen J., Courage C., Gallati S., Buerki S., Strozzi S.,
RA   Simonetti B.G., Grunt S., Steinlin M., Alber M., Wolff M., Klopstock T.,
RA   Prott E.C., Lorenz R., Spaich C., Rona S., Lakshminarasimhan M., Kroell J.,
RA   Dorn T., Kraemer G., Synofzik M., Becker F., Weber Y.G., Lerche H.,
RA   Boehm D., Biskup S.;
RT   "Targeted next generation sequencing as a diagnostic tool in epileptic
RT   disorders.";
RL   Epilepsia 53:1387-1398(2012).
CC   -!- FUNCTION: May be involved in the control of excitability of cortical
CC       neurons. {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with CUL3. {ECO:0000269|PubMed:22748208}.
CC   -!- INTERACTION:
CC       Q96MP8-2; Q6UY14-3: ADAMTSL4; NbExp=3; IntAct=EBI-11954971, EBI-10173507;
CC       Q96MP8-2; O95429: BAG4; NbExp=3; IntAct=EBI-11954971, EBI-2949658;
CC       Q96MP8-2; Q13618: CUL3; NbExp=4; IntAct=EBI-11954971, EBI-456129;
CC       Q96MP8-2; Q92997: DVL3; NbExp=3; IntAct=EBI-11954971, EBI-739789;
CC       Q96MP8-2; Q5JST6: EFHC2; NbExp=3; IntAct=EBI-11954971, EBI-2349927;
CC       Q96MP8-2; Q8NHY3: GAS2L2; NbExp=3; IntAct=EBI-11954971, EBI-7960826;
CC       Q96MP8-2; Q9H8Y8: GORASP2; NbExp=5; IntAct=EBI-11954971, EBI-739467;
CC       Q96MP8-2; Q0VD86: INCA1; NbExp=3; IntAct=EBI-11954971, EBI-6509505;
CC       Q96MP8-2; Q9C086: INO80B; NbExp=3; IntAct=EBI-11954971, EBI-715611;
CC       Q96MP8-2; Q92993: KAT5; NbExp=3; IntAct=EBI-11954971, EBI-399080;
CC       Q96MP8-2; Q96MP8-2: KCTD7; NbExp=5; IntAct=EBI-11954971, EBI-11954971;
CC       Q96MP8-2; O95678: KRT75; NbExp=3; IntAct=EBI-11954971, EBI-2949715;
CC       Q96MP8-2; Q3SY46: KRTAP13-3; NbExp=3; IntAct=EBI-11954971, EBI-10241252;
CC       Q96MP8-2; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-11954971, EBI-739832;
CC       Q96MP8-2; Q99750: MDFI; NbExp=3; IntAct=EBI-11954971, EBI-724076;
CC       Q96MP8-2; P50221: MEOX1; NbExp=3; IntAct=EBI-11954971, EBI-2864512;
CC       Q96MP8-2; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-11954971, EBI-16439278;
CC       Q96MP8-2; Q9GZT8: NIF3L1; NbExp=3; IntAct=EBI-11954971, EBI-740897;
CC       Q96MP8-2; Q96HA8: NTAQ1; NbExp=3; IntAct=EBI-11954971, EBI-741158;
CC       Q96MP8-2; Q9UBU9: NXF1; NbExp=3; IntAct=EBI-11954971, EBI-398874;
CC       Q96MP8-2; Q9HBI0: PARVG; NbExp=3; IntAct=EBI-11954971, EBI-3921217;
CC       Q96MP8-2; P26367: PAX6; NbExp=3; IntAct=EBI-11954971, EBI-747278;
CC       Q96MP8-2; Q13526: PIN1; NbExp=3; IntAct=EBI-11954971, EBI-714158;
CC       Q96MP8-2; Q99633: PRPF18; NbExp=3; IntAct=EBI-11954971, EBI-2798416;
CC       Q96MP8-2; P25786: PSMA1; NbExp=3; IntAct=EBI-11954971, EBI-359352;
CC       Q96MP8-2; P20338: RAB4A; NbExp=3; IntAct=EBI-11954971, EBI-722284;
CC       Q96MP8-2; Q04864-2: REL; NbExp=3; IntAct=EBI-11954971, EBI-10829018;
CC       Q96MP8-2; Q15560: TCEA2; NbExp=3; IntAct=EBI-11954971, EBI-710310;
CC       Q96MP8-2; Q8N8B7-2: TCEANC; NbExp=3; IntAct=EBI-11954971, EBI-11955057;
CC       Q96MP8-2; P54274-2: TERF1; NbExp=7; IntAct=EBI-11954971, EBI-711018;
CC       Q96MP8-2; Q9C040: TRIM2; NbExp=3; IntAct=EBI-11954971, EBI-749840;
CC       Q96MP8-2; O75382: TRIM3; NbExp=3; IntAct=EBI-11954971, EBI-2129889;
CC       Q96MP8-2; Q14119: VEZF1; NbExp=3; IntAct=EBI-11954971, EBI-11980193;
CC       Q96MP8-2; Q8TAU3: ZNF417; NbExp=3; IntAct=EBI-11954971, EBI-740727;
CC       Q96MP8-2; Q7Z4V0: ZNF438; NbExp=3; IntAct=EBI-11954971, EBI-11962468;
CC       Q96MP8-2; Q6S9Z5: ZNF474; NbExp=3; IntAct=EBI-11954971, EBI-17269964;
CC       Q96MP8-2; Q9H707: ZNF552; NbExp=3; IntAct=EBI-11954971, EBI-2555731;
CC       Q96MP8-2; Q96SQ5: ZNF587; NbExp=3; IntAct=EBI-11954971, EBI-6427977;
CC   -!- SUBCELLULAR LOCATION: Cell membrane. Cytoplasm, cytosol.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96MP8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96MP8-2; Sequence=VSP_020760;
CC   -!- DISEASE: Epilepsy, progressive myoclonic 3, with or without
CC       intracellular inclusions (EPM3) [MIM:611726]: A form of progressive
CC       myoclonic epilepsy, a clinically and genetically heterogeneous group of
CC       disorders defined by the combination of action and reflex myoclonus,
CC       other types of epileptic seizures, and progressive neurodegeneration
CC       and neurocognitive impairment. EPM3 is an autosomal recessive, severe,
CC       form with early onset. Multifocal myoclonic seizures begin between 16
CC       and 24 months of age after normal initial development.
CC       Neurodegeneration and regression occur with seizure onset. Other
CC       features include intellectual disability, dysarthria, truncal ataxia,
CC       and loss of fine finger movements. EEG shows slow dysrhythmia,
CC       multifocal and occasionally generalized epileptiform discharges. In
CC       some patients, ultrastructural findings on skin biopsies identify
CC       intracellular accumulation of autofluorescent lipopigment storage
CC       material, consistent with neuronal ceroid lipofuscinosis.
CC       {ECO:0000269|PubMed:17455289, ECO:0000269|PubMed:22606975,
CC       ECO:0000269|PubMed:22612257, ECO:0000269|PubMed:22693283,
CC       ECO:0000269|PubMed:22748208}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Note=Defects in KCTD7 are a cause of opsoclonus-myoclonus
CC       ataxia-like syndrome. Opsoclonus myoclonus ataxia syndrome (OMS) is a
CC       rare pervasive and frequently permanent disorder that usually develops
CC       in previously healthy children with normal premorbid psychomotor
CC       development and characterized by association of abnormal eye movements
CC       (opsoclonus), severe dyskinesia (myoclonus), cerebellar ataxia,
CC       functional regression, and behavioral problems. The syndrome is
CC       considered to be an immune-mediated disorder and may be tumor-
CC       associated or idiopathic. OMS is one of a few steroid responsive
CC       disorders of childhood. KCTD7 mutations have been found in a patient
CC       with an atypical clinical presentation characterized by non-epileptic
CC       myoclonus and ataxia commencing in early infancy, abnormal opsoclonus-
CC       like eye movements, improvement of clinical symptoms under steroid
CC       treatment, and subsequent development of generalized epilepsy
CC       (PubMed:22638565). {ECO:0000269|PubMed:22638565}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK056631; BAB71236.1; -; mRNA.
DR   EMBL; CH236961; EAL23735.1; -; Genomic_DNA.
DR   EMBL; CH471140; EAX07919.1; -; Genomic_DNA.
DR   EMBL; BC042482; AAH42482.1; -; mRNA.
DR   CCDS; CCDS55117.1; -. [Q96MP8-2]
DR   CCDS; CCDS5534.1; -. [Q96MP8-1]
DR   RefSeq; NP_001161433.1; NM_001167961.2. [Q96MP8-2]
DR   RefSeq; NP_694578.1; NM_153033.5. [Q96MP8-1]
DR   AlphaFoldDB; Q96MP8; -.
DR   SMR; Q96MP8; -.
DR   BioGRID; 127564; 84.
DR   FunCoup; Q96MP8; 791.
DR   IntAct; Q96MP8; 41.
DR   STRING; 9606.ENSP00000492240; -.
DR   iPTMnet; Q96MP8; -.
DR   PhosphoSitePlus; Q96MP8; -.
DR   BioMuta; KCTD7; -.
DR   DMDM; 74732414; -.
DR   jPOST; Q96MP8; -.
DR   MassIVE; Q96MP8; -.
DR   PaxDb; 9606-ENSP00000275532; -.
DR   PeptideAtlas; Q96MP8; -.
DR   ProteomicsDB; 77385; -. [Q96MP8-1]
DR   ProteomicsDB; 77386; -. [Q96MP8-2]
DR   Pumba; Q96MP8; -.
DR   Antibodypedia; 34857; 121 antibodies from 19 providers.
DR   DNASU; 154881; -.
DR   Ensembl; ENST00000443322.1; ENSP00000411624.1; ENSG00000243335.10. [Q96MP8-2]
DR   Ensembl; ENST00000639828.2; ENSP00000492240.1; ENSG00000243335.10. [Q96MP8-1]
DR   GeneID; 154881; -.
DR   KEGG; hsa:154881; -.
DR   MANE-Select; ENST00000639828.2; ENSP00000492240.1; NM_153033.5; NP_694578.1.
DR   UCSC; uc003tvd.5; human. [Q96MP8-1]
DR   AGR; HGNC:21957; -.
DR   CTD; 154881; -.
DR   DisGeNET; 154881; -.
DR   GeneCards; KCTD7; -.
DR   HGNC; HGNC:21957; KCTD7.
DR   HPA; ENSG00000243335; Tissue enhanced (retina).
DR   MalaCards; KCTD7; -.
DR   MIM; 611725; gene.
DR   MIM; 611726; phenotype.
DR   OpenTargets; ENSG00000243335; -.
DR   Orphanet; 263516; Progressive myoclonic epilepsy type 3.
DR   VEuPathDB; HostDB:ENSG00000243335; -.
DR   eggNOG; KOG2723; Eukaryota.
DR   GeneTree; ENSGT00940000161327; -.
DR   HOGENOM; CLU_070345_1_0_1; -.
DR   InParanoid; Q96MP8; -.
DR   OMA; IAAEQQC; -.
DR   OrthoDB; 2414723at2759; -.
DR   PAN-GO; Q96MP8; 3 GO annotations based on evolutionary models.
DR   PathwayCommons; Q96MP8; -.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; Q96MP8; -.
DR   BioGRID-ORCS; 154881; 11 hits in 1155 CRISPR screens.
DR   ChiTaRS; KCTD7; human.
DR   GeneWiki; KCTD7; -.
DR   GenomeRNAi; 154881; -.
DR   Pharos; Q96MP8; Tbio.
DR   PRO; PR:Q96MP8; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q96MP8; protein.
DR   Bgee; ENSG00000243335; Expressed in cortical plate and 178 other cell types or tissues.
DR   ExpressionAtlas; Q96MP8; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0090461; P:intracellular glutamate homeostasis; IMP:UniProtKB.
DR   GO; GO:0030007; P:intracellular potassium ion homeostasis; IEA:Ensembl.
DR   GO; GO:0060081; P:membrane hyperpolarization; IBA:GO_Central.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   CDD; cd18366; BTB_POZ_KCTD7; 1.
DR   FunFam; 3.30.710.10:FF:000046; BTB/POZ domain-containing protein KCTD7 isoform X1; 1.
DR   Gene3D; 3.30.710.10; Potassium Channel Kv1.1, Chain A; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   PANTHER; PTHR14499:SF122; BTB_POZ DOMAIN-CONTAINING PROTEIN KCTD7; 1.
DR   PANTHER; PTHR14499; POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; POZ domain; 1.
DR   neXtProt; NX_Q96MP8; -.
DR   PharmGKB; PA134884591; -.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Cytoplasm; Disease variant; Epilepsy;
KW   Membrane; Neurodegeneration; Neuronal ceroid lipofuscinosis;
KW   Proteomics identification; Reference proteome.
FT   CHAIN           1..289
FT                   /note="BTB/POZ domain-containing protein KCTD7"
FT                   /id="PRO_0000251476"
FT   DOMAIN          51..149
FT                   /note="BTB"
FT   REGION          1..35
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         289
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_020760"
FT   VARIANT         84
FT                   /note="R -> W (found in a patient with opsoclonus-myoclonus
FT                   ataxia-like syndrome; likely pathogenic;
FT                   dbSNP:rs754476100)"
FT                   /evidence="ECO:0000269|PubMed:22638565"
FT                   /id="VAR_068775"
FT   VARIANT         94
FT                   /note="R -> W (in EPM3; dbSNP:rs387907260)"
FT                   /evidence="ECO:0000269|PubMed:22606975,
FT                   ECO:0000269|PubMed:22693283"
FT                   /id="VAR_068776"
FT   VARIANT         108
FT                   /note="L -> M (in EPM3; dbSNP:rs387907263)"
FT                   /evidence="ECO:0000269|PubMed:22612257,
FT                   ECO:0000269|PubMed:22693283"
FT                   /id="VAR_068777"
FT   VARIANT         115
FT                   /note="D -> Y (in EPM3; uncertain significance;
FT                   dbSNP:rs387907262)"
FT                   /evidence="ECO:0000269|PubMed:22693283"
FT                   /id="VAR_068778"
FT   VARIANT         184
FT                   /note="R -> C (in EPM3; results in markedly diminished
FT                   localization at the cell membrane and appearance of
FT                   prominent cytoplasmic aggregates; dbSNP:rs387907246)"
FT                   /evidence="ECO:0000269|PubMed:22748208"
FT                   /id="VAR_068779"
FT   VARIANT         273
FT                   /note="N -> I (in EPM3; dbSNP:rs387907261)"
FT                   /evidence="ECO:0000269|PubMed:22693283"
FT                   /id="VAR_068780"
SQ   SEQUENCE   289 AA;  33132 MW;  1F0D1F618CD5E459 CRC64;
     MVVVTGREPD SRRQDGAMSS SDAEDDFLEP ATPTATQAGH ALPLLPQEFP EVVPLNIGGA
     HFTTRLSTLR CYEDTMLAAM FSGRHYIPTD SEGRYFIDRD GTHFGDVLNF LRSGDLPPRE
     RVRAVYKEAQ YYAIGPLLEQ LENMQPLKGE KVRQAFLGLM PYYKDHLERI VEIARLRAVQ
     RKARFAKLKV CVFKEEMPIT PYECPLLNSL RFERSESDGQ LFEHHCEVDV SFGPWEAVAD
     VYDLLHCLVT DLSAQGLTVD HQCIGVCDKH LVNHYYCKRP IYEFKITWW
//
